Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

ZEPOSIA (Ozanimod) for the Treatment of Multiple Sclerosis

Drug (Brand/Generic)

ZEPOSIA® (Ozanimod)

Developer

Bristol Myers Squibb (BMS)

Product Description

Oral capsules

Therapy Class

Sphingosine-1-phosphate receptor modulator

Current Indication

Multiple sclerosis (MS)

Market Sector

Central nervous system (CNS)

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top